Mediators and the Anti-Thrombotic Properties of the Vascular Endothelium

References

• Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin en-doperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663–5
   PubMed Web of Science ®Google Scholar
• Buchanan M. R., Haas T. A., Lagarde M., Guichardant M. 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellent factor (LOX). J. Biol Chem 1985; 260: 16056–9
   PubMedGoogle Scholar
• Hopkins N. K., Oglesby T. D., Bundy G. W., Gorman R. R. Biosynthesis and metabolism of 15-hydroperoxy-5, 8, 11, 13-eicosatetraenoic acid by human umbilical vein endothelial cells. J. Biol Chem 1984; 259: 14048–58
   Google Scholar
• Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 286: 373–6
   Google Scholar
• Jaffe E. A. Endothelial cells and the biology of factor VIII. N Engl J. Med 1977; 296: 377–86
   PubMed Web of Science ®Google Scholar
• Collen D., Lijnen H. R. Tissue-type plasminogen activator - mechanism of action and thrombolytic properties. Haemostasis 1986; 16(suppl 3)25–32
   Google Scholar
• Ross R., Raines E. W., Bowen-Pope D. F. The biology of platelet-derived growth factor. Cell 1986; 46: 155–69
   PubMed Web of Science ®Google Scholar
• Zimmerman G. A., McIntyre T. M., Prescott S. M. Production of platelet-activating factor by human vascular endothelium cells: evidence for a requirement for specific agonists and modulation by prostacyclin. Circulation 1985; 72: 718–27
   PubMedGoogle Scholar
• Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–5
   PubMed Web of Science ®Google Scholar
• Moncada S., Vane J. R. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 1979; 30: 293–331
   Web of Science ®Google Scholar
• Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (Prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976; 12: 897–913
   PubMed Web of Science ®Google Scholar
• Hong S. L., Deykin D. Activation of phospholipases A2 and C. in pig aortic endothelial cells synthesizing prostacyclin. J. Biol Chem 1982; 257: 7151–4
   PubMedGoogle Scholar
• Markey C. M., Alward A., Weller P. E., Mamett L. J. Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. J. Biol Chem 1987; 262: 6266–79
   PubMed Web of Science ®Google Scholar
• Flower R., Gryglewski R., Herbaczynska-Cedro K., Vane J. R. Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nature (New Biol) 1972; 238: 104–6
   PubMedGoogle Scholar
• Lands W. E. M. Interactions of lipid hydroperoxides with eicosanoid biosynthesis. J. Free Radicals Biol Med 1985; 1: 97–101
   PubMedGoogle Scholar
• Egan R. W., Paxton J., Kuehl F. A., Jr. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J. Biol Chem 1976; 251: 7329–35
   PubMed Web of Science ®Google Scholar
• Sagone A. L., Wells R. M., De Mocko C. Evidence that OH' production by human PMNs is related to prostaglandin metabolism. Inflammation 1980; 4: 65–71
   PubMed Web of Science ®Google Scholar
• Crutchley D. J., Ryan J. W., Ryan U. S., Fisher G. H. Bradyki-nin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Biochim Biophys Acta 1983; 751: 99–107
   PubMedGoogle Scholar
• Brandt R., Dembiriska-Kiec A., Korbut R., Gryglewski R. J., Nowak J. Release of prostacyclin from the human pulmonary vascular bed in response to cholinergic stimulation. Naunyn Schmiedebergs Arch Pharmacol 1984; 325: 69–75
   Google Scholar
• Ager A., Gordon J. L., Moncada S., Pearson J. D., Salmon J. A., Trevethick M. A. Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells. J. Cell Physiol 1982; 110: 9–16
   PubMedGoogle Scholar
• Weksler B. B., Ley C. W., Jaffe E. A. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin and the ionophore A 23187. J. Clin Invest 1978; 62: 923–30
   PubMed Web of Science ®Google Scholar
• Coughlin S. R., Moskowitz M. A., Zetter B. R., Antoniades H. N., Levine L. Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor. Nature 1980; 288: 600–2
   PubMed Web of Science ®Google Scholar
• Bailey J. M., Muza B., Hla T., Salata K. Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: regulation by epidermal growth factor. J. Lipid Res 1985; 26: 54–61
   Google Scholar
• Rossi V., Breviario F., Ghezzi P., Dejana E., Mantovani A. Prostacyclin synthesis induced in vascular cells by in-terleukin-1. Science 1985; 229: 174–6
   PubMed Web of Science ®Google Scholar
• Pearson J. D., Slakey L. L., Gordon J. L. Stimulation of prostaglandin production through purinoceptors on cultured porcine endothelial cells. Biochem J. 1983; 214: 273–6
   PubMed Web of Science ®Google Scholar
• Gryglewski R. J., Panczenko B., Korbut R., Grodzinska L., Ocetkiewicz A. Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig. Prostaglandins 1975; 10: 343–55
   PubMed Web of Science ®Google Scholar
• Flower R. J., Wood J. N., Parente W. Macrocortin and the mechanism of action of glucocorticosteroids. Adv Inflammation Res 1984; 7: 61–70
   Google Scholar
• Gryglewski R. J., Moncada S., Palmer R. M. J. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J. Pharmacol 1986; 87: 685–94
   PubMed Web of Science ®Google Scholar
• Szczeklik A., Gryglewski R. J. Low density lipoproteins (LDL) are carriers for lipid peroxides and invalidate prostacyclin (PGI2) biosynthesis in arteries. Artery 1980; 7: 489–91
   Google Scholar
• Nolan R. D., Eling T. E. Inhibition of prostacyclin synthesis in cultured bovine aortic endothelial cells by vitamin K. Biochem Pharmacol 1986; 35: 4273–81
   Google Scholar
• Chavy W. C., Murata S., Nakano J., Orimo H. Age-related decrease in prostacyclin biosynthetic activity in rat aortic smooth muscle cells. Biochim Biophys Acta 1980; 620: 159–66
   Google Scholar
• Gryglewski R. J., Dembinska-Kiec A., Zmuda A., Gryglewska T. Prostacyclin and thromboxane A2 biosynthetic capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis 1978; 31: 385–94
   PubMed Web of Science ®Google Scholar
• Tateson J. E., Moncada S., Vane J. R. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins 1977; 13: 389–97
   PubMed Web of Science ®Google Scholar
• Ito T. T., Ogawa K., Enomoto J., Hashimoto H., Kai J., Satake T. Comparison of effects of PGI2 and PGE, on coronary and systemic haemodynamics and on coronary arterial cyclic nucleotide levels in dogs. Adv Prostaglandin Thromboxane Leukotriene Res 1980; 7: 641–6
   Google Scholar
• Gryglewski R. J., Korbut R., Radomski M. (1986) Transformation of prostacyclin by horse platelet cytosol to a stable metabolite which has fibrinolytic activity in vitro. USA-Poland Symposium: Cardiovascular disease, Warsaw-. June, 1984, 9–16, NIH Publication No 86–2642
   Google Scholar
• Blackwell G. J., Radomski M., Vargas J. R., Moncada S. Prostacyclin prolongs viability of washed human platelets. Biochim Biophys Acta 1982; 718: 60–5
   Google Scholar
• Escoubet B., Griffaton G., Samuel J. L., Lechat P. Calcium antagonists stimulate prostaglandin synthesis by cultured rat cardiac myocytes and prevent the effects of hypoxia. Biochem Pharmacol 1986; 35: 4401–8
   Google Scholar
• Renkawek K., Herbaczyriska-Cedro K., Mossakowski M. J. The effect of prostacyclin on morphological and enzymatic properties of CNS cultures exposed to anoxia. Acta Neurol Scand 1986; 73: 111–8
   Google Scholar
• Bursch W., Schulte-Hermann R. Cytoprotective effect of lloprost against liver cell death induced by carbon tetrachloride (CCI4) or bromobenzene. Prostacyclin and its stable analogue lloprost, R. J. Gryglewski, G. Stock. Springer-Verlag, Berlin 1987; 257–68
   Google Scholar
• Nizankowski R., Krolikowski W., Bielatowicz J., Schaller J., Szczeklik A. Prostacyclin for ischaemic ulcers in peripheral arterial disease. A random-assignment placebo-controlled study. Prostacyclin - clinical trials, R. J. Gryglewski, A. Szczeklik, J. C. McGiff. Raven Press, New York 1985; 15–22
   Google Scholar
• Simpson P. J., Lucchesi B. R. Myocardial ischaemia: the potential role of prostacyclin and its analogues. Prostacyclin and its stable analogue lloprost, R. J. Gryglewski, G. Stock. Springer Verlag, Berlin 1987; 179–94
   Google Scholar
• Higenbottam T. The place of prostacyclin in the clinical management of primary pulmonary hypertension. Am Rev Respir Dis 1987; 136: 782–5
   Google Scholar
• Dyerberg J., Bang H. O., Stoffersen E., Moncada S., Vane J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet 1978; ii: 117–9
   Web of Science ®Google Scholar
• Kromhout D., Bosschieter E. B., de Lezenne Coulander C. D. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl J. Med 1985; 312: 1205–8
   PubMed Web of Science ®Google Scholar
• Buchanan M. R., Butt R. W., Magas Z., Van Ryn J., Hirsh J., Nazir D. J. Endothelial cells produce a lipoxygenase derived chemorepellent which influences platelet endothelial cell interactions - effect of aspirin and salicylate. Thromb Haemost 1985; 53: 306–11
   PubMed Web of Science ®Google Scholar
• Galton S. A., Sneddon J. M., Vane J. R. The formation of 13-hydroxyoctadecadienoic acid (13-HODE) by endothelial cells (EC) from different species. Br J. Pharmacol 1988; 93: 223P
   Google Scholar
• Cherry P. D., Furchgott R. F., Zawadzki J. V., Jothianadan D. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA 1982; 79: 2106–10
   PubMed Web of Science ®Google Scholar
• Toda N. Endothelium-dependent relaxation induced by angiotensin II and histamine in isolated arteries of dog. Br J. Pharmacol 1984; 81: 301–7
   PubMed Web of Science ®Google Scholar
• Van de Voorde J., Vanderstichele H., Leusen I. Release of endothelium-derived relaxing factor from human umbilical vessels. Circ Res 1987; 60: 517–22
   PubMed Web of Science ®Google Scholar
• Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 1983; 305: 627–30
   PubMed Web of Science ®Google Scholar
• Griffith T. M., Edwards D. H., Lewis M. Y., Henderson A. H. Er-gometrine-induced arterial dilatation: an endothelium-mediated effect. J. Mol Cell Cardiol 1984; 16: 479–82
   Google Scholar
• Singer H. A., Peach M. J. Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A 23187 with antagonists of arachi-donic acid metabolism. J. Pharmacol Exp Ther 1983; 226: 796–801
   Google Scholar
• Forstermann U., Burgwitz K., Frölich J. C. Thimerosal induces endothelium-dependent vascular smooth muscle relaxations by interacting with thiol groups. Relaxations are likely to be mediated by endothelium-derived relaxing factor (EDRF). Naunyn Schmiedebergs Arch Pharmacol 1986; 334: 501–7
   Google Scholar
• De Mey J. G., Claeys M., Vanhoutte P. M. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J. Pharmacol Exp Ther 1982; 222: 166–73
   PubMed Web of Science ®Google Scholar
• Förstermann U., Neufang B. Endothelium-dependent vasodiatation by melittin: are lipoxygenase products involved?. Am J Physiol 1985; 249: H14–9
   Google Scholar
• Furchgott R. F., Cherry P. D., Zawadzki J. V., Jathianandan D. Endothelial cells as mediators of vasodilation of arteries. J. Cardiovasc Pharmacol 1984; 6: S336–43
   Web of Science ®Google Scholar
• Pohl U., Holtz J., Busse R., Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986; 8: 37–44
   PubMed Web of Science ®Google Scholar
• Frank G. W., Bevan J. A. Electrical stimulation causes endothelium-dependent relaxation in lung vessels. Am J. Physiol 1983; 244: H793–8
   PubMed Web of Science ®Google Scholar
• Seidel C. L., La Rocheile J. Venous and arterial endothelial different dilator abilities in doq vessels. Circ Rpq 1987; 60: 626–30
   PubMedGoogle Scholar
• Furlong B., Henderson A. H., Lewis M. J., Smith J. A. En-dothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J. Pharmacol 1987; 90: 687–92
   PubMed Web of Science ®Google Scholar
• Radomski M. W., Palmer R. M. J., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; ii: 1057–8
   Web of Science ®Google Scholar
• Sneddon J. M., Vane J. R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988; 85: 2800–4
   PubMed Web of Science ®Google Scholar
• Griffith T. M., Edwards D. H., Lewis M. J., Henderson A. H. Evidence that cyclic guanosine monophosphate (cGMP) mediates endothelium-dependent relaxation. Eur J. Pharmcol 1985; 112: 195–202
   Google Scholar
• Young M. A., Vatner S. F. Blood flow-and endothelium-mediated vasomotion of iliac arteries in conscious dogs. Circ Res 1987; 61(suppl. II)88–93
   Google Scholar
• Chu A., Cobb F. R. Vasoactive effects of serotonin on proximal coronary arteries in awake dogs. Circ Res 1987; 61(suppl II)81–7
   Google Scholar
• Watanabe M., Rosenblum Wl., Nelson G. H. In vivo effect of methylene blue on endothelium-dependent and en-dothelium-independent dilations of brain microvessels in mice. Circ Res 1988; 62: 86–90
   Google Scholar
• Cohen R. A., Shepherd J. J., Vanhoutte P. M. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 1983; 221: 273–4
   PubMed Web of Science ®Google Scholar
• Verbeuren T. J., Jordaens F. H., Zonnekeyn L. L., Van Hove C. E., Coene M.-C., Herman A. G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxation in isolated arteries of control and hyper-cholesterolemic rabbits. Circ Res 1986; 58: 552–64
   PubMed Web of Science ®Google Scholar
• Chappel S. P., Lewis M. J., Henderson A. H. Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations. Cardiovasc Res 1987; 21: 34–8
   Google Scholar
• Harrison D. G., Freiman P. C., Armstrong M. L., Marcus M. L., Heistad D. D. Alterations of vascular reactivity in atherosclerosis. Circ. Res 1987; 61(suppl II)74–80
   Google Scholar
• Förstermann U., Miigge A., Alheid U., Haverich A., Frolich C. J. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988; 62: 185–90
   PubMed Web of Science ®Google Scholar
• Ludmer P. L., Selwyn A. P., Shook T. L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl J. Med 1986; 315: 1046–51
   PubMed Web of Science ®Google Scholar
• Lockette W., Otsuka Y., Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8(suppl II)61–6
   Google Scholar
• Winquist R. J. Altered vasodilator and endothelium-depen-dent responses in hypertension. Drug Dev Res 1986; 7: 311–8
   Google Scholar
• Lüscher T. F., Raij L., Vanhoutte P. M. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 1987; 9: 157–63
   PubMed Web of Science ®Google Scholar
• Mayhan W. G., Faraci F. M., Heistad D. D. Impairment of en-dothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J. Physiol 1987; 253
   Google Scholar
• Miller M. J. S., Pinto A., Mullane K. M. Impaired endothelium-dependent relaxations in rabbits subjected to aortic coarctation hypertension. Hypertension 1987; 10: 164–70
   PubMed Web of Science ®Google Scholar
• Murld7 F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin tnvest 1986; 78: 1–5
   Google Scholar
• Khan M. T., Furchgott R. F. Similarities of behaviour of nitric oxide (NO) and endothelium-derived relaxing factor in a perfusion cascade bioassay system. Fed Proc Fed Am Soc Exp Biol 1987; 46: 385
   Google Scholar
• Ignarro L. J., Byrns R. E., Buga G. M., Wood K. S. Endothelium-derived relaxing factor (EDRF) released from artery and vein appears to be nitric oxide (NO) or a closely related radical species. Fed Proc Fed Am Soc Exp Biol 1987; 46: 644
   Google Scholar
• Palmer R. M. J., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–6
   PubMed Web of Science ®Google Scholar
• Vane J. R. The use of isolated organs for detecting active substances in the circulating blood. Br J. Pharmacol Chemother 1964; 23: 360–73
   PubMed Web of Science ®Google Scholar
• Gryglewski R. J., Palmer R. M. J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454–6
   PubMed Web of Science ®Google Scholar
• Ignarro L. J., Byrns R. E., Buga G. M., Wood K. S., Chaudhuri G. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 1987; 244: 181–9
   Web of Science ®Google Scholar
• Radomski M. W., Palmer R. M.J., Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J. Pharmacol 1987; 92: 181–7
   PubMed Web of Science ®Google Scholar
• Radomski M. W., Palmer R. M. J., Moncada S. The anti-ag-gregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J. Pharmacol 1987; 92: 639–46
   PubMed Web of Science ®Google Scholar
• De Nucci G., Gryglewski R. J., Warner T. D., Vane J. R. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells in coupled. Proc Natl Acad Sci USA 1988; 85: 2334–8
   PubMed Web of Science ®Google Scholar
• Forsberg E. J., Feuerstein G., Shohami E., Pollard H. B. Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. Proc Natl Acad Sci USA 1987; 84: 5630–4
   PubMed Web of Science ®Google Scholar
• Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1–46
   PubMed Web of Science ®Google Scholar
• Berridge M. J., Irvine R. F. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312: 315–21
   PubMed Web of Science ®Google Scholar
• Lambert T. L., Kent R. S., Whorton A. R. Bradykinin stimulation of inositol polyphosphate production in porcine aortic endothelial cells. J. Biol Chem 1986; 261: 15288–93
   PubMedGoogle Scholar
• Blackwell G. J., Flower R. J., Nijkamp F. P., Vane J. R. Phos-pholipase A2 activity of guinea-pig isolated perfused lungs- stimulation and inhibition by anti-inflammatory steroids. Br J Pharmacol 1978; 62: 79–89
   PubMed Web of Science ®Google Scholar
• Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the antiphospholipase effect of glucocorticoids. Nature 1980; 287: 147–9
   PubMed Web of Science ®Google Scholar
• Forstermann U., Burgwitz K., Frolich J. C. Effects of nonsteroidal phospholipase inhibitors and glucocorticoids on endothelium-dependent relaxations of rabbit aorta induced by different agents. J. Cardiovasc Pharmacol 1987; 10: 356–64
   Google Scholar
• Bell R. L., Kennerly D. A., Stanford N., Majerus P. W. Diglycer-ide lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci USA 1979; 76: 3238–41
   PubMed Web of Science ®Google Scholar
• de Chaffoy de Courcelles D., Roevens P., Van Belle H. R. 59 022, a diacylglycerol kinase inhibitor. Its effect on di-acylglycerol and thrombin-induced C kinase activation in the intact platelet. J. Biol Chem 1985; 260: 15762–70
   PubMedGoogle Scholar
• Nishizuka Y. The role of protein kinase C. in cell surface signal transduction and tumour promotion. Nature 1984; 308: 693–8
   PubMed Web of Science ®Google Scholar
• Brown K. D., Blakeley D. M., Hamon M. H., Lauries M. S., Corps A. N. Protein kinase C-mediated negative-feedback inhibition of unstimulated and bombesin-stimulated polyphosphoinositide hydrolysis in Swiss-mouse 3T3 cells. Biochem J. 1987; 245: 631–9
   PubMed Web of Science ®Google Scholar
• Smith C. D., Uhing R. J., Snyderman R. Nucleotide regulatory protein-mediated activation of phospholipase C. in human polymorphonuclear leukocytes is disrupted by phorbol esters. J. Biol Chem 1987; 262: 6121–7
   PubMed Web of Science ®Google Scholar
• Lewis M. J., Henderson A. H. A phorbol ester inhibits the release of endothelium-derived relaxing factor. Eur J. Pharmacol 1987; 137: 167–71
   PubMed Web of Science ®Google Scholar
• Matsubara T., Ziff M. Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J. Cell Physiol 1986; 127: 207–10
   PubMed Web of Science ®Google Scholar
• Martin W., Villani G. M., Jothianandan D., Furchgott R. F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol Exp Ther 1985; 232: 708–16
   PubMed Web of Science ®Google Scholar
• Luckhoff A., Busse R. Increased free calcium in endothelial cells under stimulation with adenine nucleotides. J. Cell Physiol 1986; 126: 414–20
   PubMed Web of Science ®Google Scholar
• Hibbs J. B., Taintor R. R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine and imino nitrogen oxidation to nitrite. Science 1987; 235: 473–76
   PubMed Web of Science ®Google Scholar
• Iyengar R., Stuehr D. J., Marietta M. A. Macrophage synthesis of nitrite, nitrate and N-nitrosamines: Precursors and role of the respiratory burst. Proc Natl Acad Sci USA 1987; 84: 6369–73
   PubMed Web of Science ®Google Scholar
• Alston T. A., Porter D. J. T., Bright H. J. Generation of nitric oxide by enzymatic oxidation of N-hydroxy-N-nitrosamines. J. Biol Chem 1985; 260: 4069–74
   Google Scholar
• Slnha B. K. Irreversible binding of quinacrine to nucleic acids during horseradish peroxidase- and prostaglandin synthetase-catalyzed oxidation. Biochem Pharmacol 1983; 32: 2604–7
   Google Scholar
• Deguchi T., Yoshioka M. L-arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J. Biol Chem 1982; 257: 10147–51
   PubMedGoogle Scholar
• Thomas G., Mostaghim R., Ramwell P. W. Endothelium dependent vascular relaxation by arginine containing polypeptides. Biochem Biophys Res Commun 1986; 141: 446–51
   Google Scholar
• Schmidt H. HHW., Klein M. M., Niroomand F., Böhme E. Is arginine a physiological precursor of endothelium-derived nitric oxide?. Eur J Pharmacol 1988; 148: 293–5
   PubMed Web of Science ®Google Scholar
• Rimele T. J., Sturm R. J., Adams L. M., Henry D. E., Heaslip R. J., Weichman B. M., Grimes D. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J. Pharmacol Exp Ther 1988; 245: 102–11
   PubMed Web of Science ®Google Scholar